Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Always Active
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

GARDP Request for Proposal for the Assessment of AMR Dx and Abx Use in India

Closing date: 13.10.2023

GARDP and FIND together is planning to implement the project to identify the existing gaps in the present AMR but also wants to work closely with the Institutes and KOL’s to create pathways to introduce newer antibiotics in the system.

The aim of this project is to assess AMR laboratory capacity, antibiotic use and existing Stewardship practices to prepare for introduction of cefiderocol (and other antibiotics) and new low blood culture and molecular point of care treatment platforms in Kenya and India. To define a go to market strategy for the AMR products, there’s need for a better understanding of current practices at both private and public hospitals at high/quaternary, tertiary and district level, in the selected countries.

 

If you are interested to receive complete documentation of this RFP, please send a request to: RFP_Procurement@gardp.org.

 

Closing date: October 13th 2023